When it comes to drug therapy most of the recent buzz has been triggered by data on tirzepatide released at the American Diabetes Association 84th Scientific Sessions, suggesting that the drug may obviate the need for continuous positive airway pressure (CPAP) in nearly half of OSA patients.
The state of assessment and treatment for obstructive sleep apnea (OSA) is in rapid flux—from changes to treatment paradigms to new pharmaceuticals, experts said in a panel session here at the Combined Otolaryngology Spring Meetings.
Identifying and managing sensing lead malfunction in upper airway stimulation devices using the Inspire Medical Systems’ upper airway stimulation (UAS) device to treat patients with moderate to severe obstructive sleep apnea (OSA), to necessitate revision surgery.
Age and smoking, but not body mass index, are associated with laryngopharyngeal reflux (LPR).
BRP and ESP procedure outcomes are comparable in the improvement of obstructive sleep apnea (OSA) with palatal collapse, although further trials and long-term follow-up are needed.
Screening for depression in patients with OSA would be worthwhile because there is a high rate of comorbidity, and both are intertwined in their pathophysiology and management.
Post-treatment improvements in visual analogue scale (VAS) scores, daytime sleepiness, and quality of life were observed after the Elevoplasty procedure.
A look at the satisfaction rates, recommendations, regrets, subjective taste disturbances, and individually reported side effects after a modified uvulopalatopharyngoplasty (UPPP) technique to treat obstructive sleep apnea.
In patients with high blood pressure resistant to treatment who also have obstructive sleep apnea, the more severe their OSA, the higher their blood pressure
Multiple therapeutic options may be effective for treating mild pediatric OSA including observation, management with anti-inflammatory medications, and surgery.